Premarket Mover: Design Therapeutics Inc (DSGN) Down 3.23%

Design Therapeutics Inc (DSGN) is lower by Wednesday morning, with the stock falling -3.23% in pre-market trading to 2.1. DSGN's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, Design Therapeutics Inc ranks higher than 0% of stocks. Design Therapeutics Inc has fallen 68.73% over the past month, closing at $6.95 on July 19. During this period of time, the stock fell as low as $6.95 and as high as $8.31. DSGN has an average analyst recommendation of Strong Buy. The company has an average price target of $26.50.

DSGN has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on DSGN!

See Full DSGN Report

Design Therapeutics Inc has a Long-Term Technical rank of 27. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 73% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, DSGN ranks better than 126% of stocks.

Important Dates for Investors in DSGN:

-Design Therapeutics Inc is set to release earnings on 2023-11-12. Over the last 12 months, the company has reported EPS of $-1.25. -We do not have a set dividend date for Design Therapeutics Inc at this time. Click Here To Get The Full Report on Design Therapeutics Inc (DSGN)